|
Market Closed -
Euronext Paris
09:25:00 02/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 6.660 EUR | -1.48% |
|
-6.46% | +6.56% |
| Market Cap | 3.75Cr 4.22Cr 3.5Cr 3.19Cr 6.02Cr 405.88Cr 6.07Cr 42Cr 16Cr 207.49Cr 16Cr 16Cr 665.91Cr | P/E 2026 * |
-17.1x | P/E 2027 * | 167x |
|---|---|---|---|---|---|
| Enterprise Value | 3.6Cr 4.05Cr 3.36Cr 3.06Cr 5.78Cr 389.65Cr 5.83Cr 41Cr 16Cr 199.19Cr 15Cr 15Cr 639.28Cr | EV / Sales 2026 * |
3.27x | EV / Sales 2027 * | 2.29x |
| Free-Float |
14.95% | Yield 2026 * |
-
| Yield 2027 * | - |
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| ALSMA | Real-time | |
Börse Stuttgart
| G3O | Delayed | |
Deutsche Boerse AG
| G3O | Delayed |
| 1 day | -1.48% | ||
| 1 week | -6.46% | ||
| Current month | -1.48% | ||
| 1 month | -11.90% | ||
| 3 months | -19.76% | ||
| 6 months | -7.50% | ||
| Current year | +6.56% |
| 1 week | 6.54 | 7.52 | |
| 1 month | 6.16 | 7.66 | |
| Current year | 6 | 9.1 | |
| 1 year | 5.9 | 9.1 | |
| 3 years | 2.25 | 9.1 | |
| 5 years | 1.9 | 9.1 | |
| 10 years | 1.9 | 9.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 29/12/2008 | |
Renaut Fritsch
DFI | Director of Finance/CFO | - | 01/06/2022 |
Thibaut Bastien
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 30/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.48% | -6.46% | -2.77% | +158.14% | 4.22Cr | ||
| -0.61% | -3.43% | +39.40% | +112.31% | 1,01900Cr | ||
| -1.02% | -5.60% | +37.67% | +65.02% | 62TCr | ||
| +1.11% | -0.58% | +11.10% | +77.28% | 46TCr | ||
| +0.34% | -3.01% | +61.21% | +40.71% | 36TCr | ||
| -0.95% | -4.05% | +21.60% | +39.37% | 33TCr | ||
| -1.46% | -2.89% | +11.84% | +24.60% | 27TCr | ||
| -1.35% | -5.43% | -4.69% | +8.40% | 24TCr | ||
| -1.04% | -2.79% | +35.52% | +51.34% | 22TCr | ||
| -1.87% | -4.10% | +30.92% | +95.33% | 18TCr | ||
| Average | -0.36% | -3.70% | +24.18% | +67.25% | 36.97TCr | |
| Weighted average by Cap. | +0.42% | -3.33% | +30.52% | +68.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.1Cr 1.24Cr 1.03Cr 93.58L 1.76Cr 119.02Cr 1.78Cr 12Cr 4.81Cr 61Cr 4.65Cr 4.55Cr 195.27Cr | 1.6Cr 1.8Cr 1.49Cr 1.36Cr 2.57Cr 173.11Cr 2.59Cr 18Cr 7Cr 88Cr 6.76Cr 6.61Cr 284.02Cr |
| Net income | -22.5L -25.32L -21L -19.14L -36.1L -24Cr -36.44L -2.54Cr -98.48L -12Cr -95.08L -93.01L -40Cr | 2L 3L 2L 2L 4L 2.7Cr 4L 28.24L 10.94L 1.38Cr 10.56L 10.33L 4.44Cr |
| Net Debt | -15L -16.88L -14L -12.76L -24.07L -16Cr -24.29L -1.69Cr -65.65L -8.3Cr -63.38L -62.01L -27Cr | -9L -10.13L -8L -8L -14.44L -9.74Cr -14.57L -1.02Cr -39.39L -4.98Cr -38.03L -37.21L -16Cr |
Employees
45
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/26/02 | €6.660 | -1.48% | 26 |
| 01/26/01 | €6.760 | 0.00% | 2 |
| 30/26/30 | €6.760 | -0.59% | 1,137 |
| 29/26/29 | €6.800 | -0.29% | 776 |
| 28/26/28 | €6.820 | -4.21% | 1,177 |
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
6.660EUR
Average target price
8.200EUR
Spread / Average Target
+23.12%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALSMA Stock
Select your edition
All financial news and data tailored to specific country editions

















